DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant March 7, 2013 • 8:00 AM EST
DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors February 28, 2013 • 1:21 PM EST
DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement February 25, 2013 • 7:00 AM EST
DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement February 11, 2013 • 8:30 AM EST
DelMar Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement January 31, 2013 • 6:07 PM EST
DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies January 25, 2013 • 12:50 PM EST
DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting November 15, 2012 • 12:00 AM EST
DelMar CEO Delivers Keynote Address at International Drug Discovery Science and Technology Conference November 8, 2012 • 12:00 AM EST
DelMar Pharmaceuticals Expands Collaboration with Guangxi Wuzhou Pharmaceutical Company October 29, 2012 • 12:00 AM EDT